Lilly and Merck’s Immuno-Oncology Collaboration Adding Abemaciclib and KEYTRUDA Combination Trial
Eli Lilly and Merck, known as MSD outside the United States and Canada, today announced another immuno-oncology collaboration that will evaluate abemaciclib... Read More
Lilly Announces Diabetes Research Partnership with University of Surrey
Eli Lilly and Company today announced a five-year research partnership with the University of Surrey to study health outcomes, focusing on the... Read More